Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutationsKeita Masuzawa, Tomoko Betsuyaku|Oncotarget|2017Cited by 55
Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutationsHanako Hasegawa, Kenzo Soejima, Hiroyuki Yasuda et al.|Lung Cancer|2018Cited by 50
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung CancerKota Ishioka, Koichi Fukunaga, Mari Ozaki et al.|Cancer Research|2021Cited by 43
Intracellular levels of reactive oxygen species correlate with ABT‐263 sensitivity in non‐small‐cell lung cancer cellsKeiko Ohgino, Kenzo Soejima, Hideki Terai et al.|Cancer Science|2020Cited by 13
Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung CancerTetsuo Tani, Kenzo Soejima, Ichiro Nakachi et al.|Cancer Management and Research|2021Cited by 7